As of 2026-02-17, the Relative Valuation of Bioatla Inc (BCAB) is (6.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 USD, the upside of Bioatla Inc based on Relative Valuation is -4254.7%.
The range of the Relative Valuation is (5.24) - (6.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 20.1x | 18.7x |
| Forward P/E multiples | 13.5x - 18.2x | 16.9x |
| Fair Price | (5.24) - (6.36) | (6.23) |
| Upside | -3591.8% - -4338.8% | -4254.7% |
| Date | P/E |
| 2026-02-13 | -0.43 |
| 2026-02-12 | -0.47 |
| 2026-02-11 | -0.53 |
| 2026-02-10 | -0.57 |
| 2026-02-09 | -0.54 |
| 2026-02-06 | -0.60 |
| 2026-02-05 | -0.54 |
| 2026-02-04 | -0.60 |
| 2026-02-03 | -0.54 |
| 2026-02-02 | -0.49 |
| 2026-01-30 | -0.77 |
| 2026-01-29 | -0.82 |
| 2026-01-28 | -0.89 |
| 2026-01-27 | -0.93 |
| 2026-01-26 | -1.01 |
| 2026-01-23 | -1.01 |
| 2026-01-22 | -0.91 |
| 2026-01-21 | -0.86 |
| 2026-01-20 | -0.92 |
| 2026-01-16 | -0.92 |
| 2026-01-15 | -0.91 |
| 2026-01-14 | -0.97 |
| 2026-01-13 | -0.88 |
| 2026-01-12 | -0.90 |
| 2026-01-09 | -1.03 |
| 2026-01-08 | -1.14 |
| 2026-01-07 | -1.21 |
| 2026-01-06 | -1.23 |
| 2026-01-05 | -1.21 |
| 2026-01-02 | -1.53 |
| 2025-12-31 | -1.62 |
| 2025-12-30 | -2.05 |
| 2025-12-29 | -2.24 |
| 2025-12-26 | -2.38 |
| 2025-12-24 | -2.07 |
| 2025-12-23 | -1.91 |
| 2025-12-22 | -2.28 |
| 2025-12-19 | -2.15 |
| 2025-12-18 | -2.26 |
| 2025-12-17 | -2.23 |
| 2025-12-16 | -2.17 |
| 2025-12-15 | -2.21 |
| 2025-12-12 | -2.35 |
| 2025-12-11 | -2.24 |
| 2025-12-10 | -2.21 |
| 2025-12-09 | -2.30 |
| 2025-12-08 | -2.31 |
| 2025-12-05 | -2.35 |
| 2025-12-04 | -2.42 |
| 2025-12-03 | -2.36 |